REGORAFENIB ANHYDROUS Pharmacologic Class Indexing

Class set ID
2d307343-fb49-4d76-ac98-f2cffe190d79
Version
3
Effective date
20230426
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. STIVARGA® (regorafenib) tablets, for oral use Initial U.S. Approval: 2012Bayer HealthCare Pharmaceuticals Inc. | Sharp Corporation | Bayer AG2026020936